MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6506-1440-1451$20.00
Mol Pharmacol 65:1440-1451, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klöss, S.
Right arrow Articles by Mülsch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klöss, S.
Right arrow Articles by Mülsch, A.

Down-Regulation of Soluble Guanylyl Cyclase Expression by Cyclic AMP Is Mediated by mRNA-Stabilizing Protein HuR

Stephan Klöss, Rashi Srivastava, and Alexander Mülsch

Institut für Kardiovaskuläre Physiologie, Johann Wolfgang v. Goethe-Universität, Frankfurt/Main, Germany

We analyzed whether the cyclic AMP induced down-regulation of the nitric oxide (NO) receptor soluble guanylyl cyclase (sGC) is mediated by the mRNA-protecting protein HuR. Exposure (up to 24 h) of isolated rat aortic segments to the activator of adenylyl cyclase, forskolin (10 µM), and to both activators of cAMP-stimulated protein kinase (PKA), 5,6-dichloro-1-{beta}-D-ribofuranosylbenzimidazole-3',5'-cyclic monophosphorothioate, Spisomer (Sp-5,6-DCl-cBIMPS; 400 nM), and N6-phenyl-cAMP (10 µM), strongly reduced sGC{alpha}1{beta}1 and HuR protein and mRNA expression in a time-dependent and actinomycin D (10 µM)-sensitive fashion. In vitro degradation of sGC{alpha}1 and {beta}1 poly(A)+ mRNA by native rat aortic protein was markedly increased by pretreatment of intact aortas with forskolin. Native protein extract from rat aorta shifted the electrophoretic mobility of biotin-labeled riboprobes from the 3'-untranslated region of sGC{alpha}1 and {beta}1 mRNA, and these bands was supershifted by a monoclonal antibody directed against the mRNA-stabilizing protein HuR. Forskolin decreased the HuR-sGC{alpha}1 and {beta}1 mRNA interaction and HuR protein expression in rat aorta, and this was prevented by the PKA inhibitory cAMP analog 3',5'-cyclic monophosphorothioate, Rp-isomer (Rp-cAMPS). In cultured smooth muscle cells from rat aorta, forskolin induced a rapid increase in Fos/p-Fos protein levels and activator protein 1 (AP-1) binding activity. Inhibition of this transcription factor by an AP-1 decoy prevented the forskolin-induced down-regulation of HuR. We conclude that forskolin/cAMP decrease the expression of heterodimeric sGC in rat aortic smooth muscle cells via activation of Fos/AP-1, which decreases the expression of HuR and thus destabilizes the sGC{alpha}1 and {beta}1 mRNA.


Received August 13, 2003; accepted February 27, 2004

Address correspondence to: Stephan Kloess, Institut für Kardiovaskuläre Physiologie, Universität Frankfurt, Theodor-Stern-Kai 7, D-60590 Frankfurt. E-mail: s.kloess{at}em.uni-frankfurt.de




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. G. Sharina, F. Jelen, E. P. Bogatenkova, A. Thomas, E. Martin, and F. Murad
{alpha}1 Soluble Guanylyl Cyclase (sGC) Splice Forms as Potential Regulators of Human sGC Activity
J. Biol. Chem., May 30, 2008; 283(22): 15104 - 15113.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. Glynos, A. Kotanidou, S. E. Orfanos, Z. Zhou, D. C. M. Simoes, C. Magkou, C. Roussos, and A. Papapetropoulos
Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1448 - R1455.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
Y. Jiang and S. S Stojilkovic
Molecular cloning and characterization of {alpha}1-soluble guanylyl cyclase gene promoter in rat pituitary cells
J. Mol. Endocrinol., December 1, 2006; 37(3): 503 - 515.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Jurado, F. Rodriguez-Pascual, J. Sanchez-Prieto, F. M. Reimunde, S. Lamas, and M. Torres
NMDA induces post-transcriptional regulation of {alpha}2-guanylyl-cyclase-subunit expression in cerebellar granule cells
J. Cell Sci., April 15, 2006; 119(8): 1622 - 1631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. S. Krumenacker, A. Kots, and F. Murad
Effects of the JNK inhibitor anthra[1,9-cd]pyrazol-6(2H)-one (SP-600125) on soluble guanylyl cyclase {alpha}1 gene regulation and cGMP synthesis
Am J Physiol Cell Physiol, October 1, 2005; 289(4): C778 - C784.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. S. Wolin
Loss of Vascular Regulation by Soluble Guanylate Cyclase Is Emerging as a Key Target of the Hypertensive Disease Process
Hypertension, June 1, 2005; 45(6): 1068 - 1069.
[Full Text] [PDF]


Home page
HypertensionHome page
S. Kloss, D. Rodenbach, R. Bordel, and A. Mulsch
Human-Antigen R (HuR) Expression in Hypertension: Downregulation of the mRNA Stabilizing Protein HuR in Genetic Hypertension
Hypertension, June 1, 2005; 45(6): 1200 - 1206.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. K. Wickenheisser, V. L. Nelson-DeGrave, and J. M. McAllister
Dysregulation of Cytochrome P450 17{alpha}-Hydroxylase Messenger Ribonucleic Acid Stability in Theca Cells Isolated from Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1720 - 1727.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. C. Browner, N. B. Dey, K. D. Bloch, and T. M. Lincoln
Regulation of cGMP-dependent Protein Kinase Expression by Soluble Guanylyl Cyclase in Vascular Smooth Muscle Cells
J. Biol. Chem., November 5, 2004; 279(45): 46631 - 46636.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics